Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1055 of 1,261

  1. US 7402659

    Thymic stromal lymphopoietin receptor molecules and uses thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  2. US 7402595

    JNK inhibitor

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  3. US 7402590

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  4. US 7402578

    Methods for inhibiting cognitive deterioration in adults with down's syndrome

    Corcept Therapeutics Incorporated · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  5. US 7402299

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  6. US 7399823

    Antimicrobial theta defensins and methods of using same

    The Regents of the University of California · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  7. US 7399827

    Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  8. US 7399863

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  9. US 7399862

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  10. US 7399750

    Methods for cardiac gene transfer

    The Regents of the University of California · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  11. US 7399612

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  12. US 7399488

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  13. US 7399465

    Pharmaceutical compositions for treating arthritis and inflammatory disease

    The Regents of the University of California · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  14. US 7399606

    Methods for identifying IκB Kinase (IKK) inhibitors

    The Regents of the University of California · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  15. US 7399759

    1, 3-benzothiazinone derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  16. US 7399485

    Rapidly Disintegrable solid preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  17. US 7396816

    Low-molecular weight peptides inhibiting ion channel activity

    Pharmadesign, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  18. US 7396848

    Neurotrophin production/secretion promoting agent

    Takeda Pharmaceutical Company Limited · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  19. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  20. US 7396664

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  21. US 7396682

    Method for cell adhesion and wound healing

    REGENBiotech, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  22. US 7396839

    Crystalline forms of gatifloxacin

    Teva Pharmaceuticals USA, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  23. US 7396918

    IGF-I fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  24. US 7396933

    Quinolinone-carboxamide compounds

    Theravance, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.